FDAnews
www.fdanews.com/articles/70779-bioelectronics-announces-distribution-agreement-with-pd-rx

BioElectronics Announces Distribution Agreement With PD-Rx

April 6, 2005

BioElectronics, a developer of advanced, disposable, therapeutic medical devices, announced that it has entered into an agreement with PD-Rx for PD-Rx to distribute ActiPatch Therapy to physicians and healthcare providers that participate in the PD-Rx programs.

ActiPatch Therapy is a dermal patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for a few dollars a day. The patch delivery system and the company's patented technology provides an inexpensive, self-administered equivalent of the operator-administered pulsed electromagnetic energy therapy used extensively worldwide to reduce swelling, relieve pain and enhance the healing of post-surgical incisions, chronic wounds (bedsores) and orthopedic conditions.